Shorter moxifloxacin-based regimens for drug-sensitive tuberculosis[2]

New England Journal of Medicine

Volumn 372, Issue 6, 2015, Pages 577-

  Sellier, Pierre O ^a   Clevenbergh, Philippe ^a   Bergmann, Jean François ^a  

^a HÔPITAL LARIBOISIÈRE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

MOXIFLOXACIN; QUINOLONE DERIVATIVE; TUBERCULOSTATIC AGENT;

BACTERIAL GENOME; BACTERIAL STRAIN; BACTERIUM CULTURE; CLONE; COMPARATIVE STUDY; CONTROLLED STUDY; DIFFERENTIAL DIAGNOSIS; DRUG TREATMENT FAILURE; GENE SEQUENCE; GENETIC VARIABILITY; HUMAN; INTERSPERSED REPEAT; LETTER; PREVALENCE; REINFECTION; RELAPSE; SEQUENCE ANALYSIS; TREATMENT DURATION; TUBERCULOSIS; FEMALE; ISOLATION AND PURIFICATION; MALE; MYCOBACTERIUM TUBERCULOSIS; TUBERCULOSIS, PULMONARY;

ANTITUBERCULAR AGENTS; FEMALE; FLUOROQUINOLONES; HUMANS; MALE; MYCOBACTERIUM TUBERCULOSIS; TUBERCULOSIS, PULMONARY;

EID: 84922326998     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMc1414718     Document Type: Letter

References (4)

1. Bryant JM, Harris SR, Parkhill J, et al. Whole-genome sequencing to establish relapse or re-infection with Mycobacterium tuberculosis: a retrospective observational study. Lancet Respir Med 2013;1:786-92.
2. Walker TM, Ip CL, Harrell RH, et al. Whole-genome sequencing to delineate Mycobacterium tuberculosis outbreaks: a retrospective observational study. Lancet Infect Dis 2013;13:137-46.
3. Niemann S, Köser CU, et al. Genomic diversity among drug sensitive and multidrug resistant isolates of Mycobacterium tuberculosis with identical DNA fingerprints. PLoS One 2009;4(10):e7407.
4. Wood R, Lawn SD, Caldwell J, Kaplan R, Middelkoop K, Bekker LG. Burden of new and recurrent tuberculosis in a major South African city stratified by age and HIV-status. PLoS One 2011;6(10):e25098.